Allena Pharmaceuticals, Inc.
ALNADelisted Sep 14, 2022- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001624658
Allena Pharmaceuticals, Inc. was delisted on Sep 14, 2022; its insiders filed their last Form 4 on Feb 2, 2022; 25 institutions reported holding it in 13F filings for Q2 2022, worth $1.71M in total; no superinvestor held it.
Holders of 5% or more of ALNA
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Allena Pharmaceuticals, Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Allena Pharmaceuticals, Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
9 Schedule 13D and 13G filings on Allena Pharmaceuticals, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Feb 14, 2023 | Third Rock Ventures II, L.P. | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2022 | Point72 Asset Management, L.P. | 13G/AOld format | – | – | – | SEC |
| Jan 28, 2022 | Frazier Healthcare VI, L.P. | 13G/AOld format | – | – | – | SEC |
| Jan 25, 2022 | Hirschman Orin | 13G/AOld format | – | – | – | SEC |
| Feb 16, 2021 | Deer VII & Co. Ltd. | 13G/AOld format | – | – | – | SEC |
| Feb 8, 2021 | FMR LLC | 13G/AOld format | – | – | – | SEC |
| Jan 25, 2021 | Hirschman Orin | 13GOld format | – | New | – | SEC |
| Jan 13, 2021 | Empery Asset Management, LP | 13GOld format | – | New | – | SEC |
| Jan 6, 2021 | Sabby Management, LLC | 13G/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Allena Pharmaceuticals, Inc. shares.
No Form 144 notices for Allena Pharmaceuticals, Inc. are on file.